WHO Launches New AI Hub to Revolutionize Global Disaster Response
Highlights: WHO’s Eastern Mediterranean office launched a new AI Community of Practice for disaster and emergency response surveillance on 16
News
PAHO Opens New Long-term Care Policy Push for Latin America and The Caribbean
Highlights: PAHO has released a new set of policy briefs to help countries strengthen long-term care in Latin America and
Frontline Voices Shape Health System Reform in The Gambia
When a hospital runs low on oxygen and staff are forced to buy it from private providers at high cost,
WHO Framework on Regulatory Considerations for Artificial Intelligence in Healthcare: Key Rules Explained
Highlights: WHO has set out a clear framework for regulatory considerations for artificial intelligence in healthcare. The focus stays on
Ifosfamide Shortage EU Expected to Persist Into 2027 Amid Supply Constraints
The Ifosfamide Shortage EU situation is set to continue well into the first quarter of next year, according to the European Medicines
Xpovio Myelofibrosis Trial Shows Mixed Results, Raises Questions on Approval Path
The Xpovio Myelofibrosis Trial has delivered mixed results, creating both optimism and uncertainty around the future of the therapy. Karyopharm Therapeutics announced that its
Merck Terns Pharma Acquisition Signals Strategic Shift in Oncology Pipeline
The Merck Terns Pharma Acquisition is emerging as one of the most closely watched deals in the pharmaceutical sector, with
India Weight Loss Drug Regulation Tightens After Surge in Generic SemaglutideLaunches
The Indian Weight Loss Drug Regulation landscape is undergoing a significant shift as authorities move swiftly to curb the unauthorised sale and
CVS Insulin Pricing Settlement Signals Shift Toward Transparency in Drug Costs
The CVS Insulin Pricing Settlement marks a significant development in the ongoing scrutiny of pharmacy benefit managers and their role
Recent Posts
